ELI LILLY GROUP LIMITED
Get an alert when ELI LILLY GROUP LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-25 (in 6mo)
Last made up 2025-11-11
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£108M
0% vs 2023
Employees
—
Average over period
Profit before tax
£20M
0% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £20,000,000 | £20,000,000 | |
| Profit before tax | £20,000,000 | £20,000,000 | |
| Net profit | £20,000,000 | £20,000,000 | |
| Cash | — | — | |
| Total assets less current liabilities | — | — | |
| Net assets | £108,491,000 | £108,491,000 | |
| Equity | £108,491,000 | £108,491,000 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young Chartered Accountants
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have no reason to believe that a material uncertainty exists that may cast significant doubt about the ability of the company to continue as a going concern. The company participates in the group's centralised treasury arrangements and so shares banking arrangements with its parent and fellow subsidiaries. Accordingly, the directors continue to adopt the going concern basis in preparing the Annual Report and financial statements for the year ended 31 December 2024.”
Group structure
- ELI LILLY GROUP LIMITED · parent
- Eli Lilly and Company Limited 100%
- Lilly Industries Limited 100%
- Eli Lilly Leasing Limited 100%
- Greenfield Pharmaceuticals Limited 100%
- Lilly Research Centre Limited 100%
- Eli Lilly Group Pension Trustees Limited 100%
Significant events
- “Following confirmation of the dividend declared by Eli Lilly and Company Limited on 21 July 2025 of £20,000,000 to Eli Lilly Group Limited, the company declared a dividend for £20,000,000 to be paid on 1 August 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 39 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| STOKES, Christopher J | Director | 2024-07-03 | Feb 1979 | American |
| WRIGHT, Kristina Mignon | Director | 2025-08-08 | Nov 1978 | American |
Show 39 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BENNETT, Hamish John Carmichael | Secretary | 2016-05-02 | 2021-02-11 |
| BURTON, Anya Louise | Secretary | 2009-05-01 | 2011-06-16 |
| BURTON, Anya Louise | Secretary | 2007-06-20 | 2008-09-12 |
| HARPER, Simon Robert | Secretary | 2011-06-16 | 2014-02-01 |
| HARPER, Simon Robert | Secretary | 2008-09-12 | 2009-05-01 |
| HARPER, Simon Robert | Secretary | 2006-05-26 | 2007-06-20 |
| JEPHSON, Wendy Jane | Secretary | 2003-03-01 | 2004-08-25 |
| JEPHSON, Wendy Jane | Secretary | 2001-06-30 | 2002-01-18 |
| OSMAN, Julie | Secretary | 2002-01-18 | 2003-02-28 |
| PEZZACK, Susan Dawn | Secretary | 2014-02-01 | 2016-05-02 |
| UPSHALL, John | Secretary | — | 2001-06-30 |
| WORDEN, Timothy James Ashpole | Secretary | 2004-08-26 | 2006-05-26 |
| BAILEY, Richard Alan | Director | — | 1993-12-16 |
| BENNETT, Hamish John Carmichael | Director | 2016-05-02 | 2021-02-11 |
| BLAIKIE, John Murdoch | Director | — | 2000-01-31 |
| BODEM, Barbara Wilson | Director | 2006-06-08 | 2011-06-16 |
| BOTT, Martin | Director | 2000-01-31 | 2003-03-31 |
| CLARK, Alan Stuart | Director | — | 1995-11-16 |
| COSSERY, Jean-Michel Yves, Sylvain | Director | 2012-12-18 | 2016-07-01 |
| CZAPAR, Michael | Director | 2021-01-01 | 2023-02-01 |
| DEMAYO STEELE, Laura | Director | 2021-07-05 | 2024-07-03 |
| DIAZ-GRANADOS, Ashley | Director | 2018-12-01 | 2021-07-05 |
| HARPER, Simon Robert | Director | 2006-03-17 | 2014-02-01 |
| HARVEY, Paul Sydney | Director | — | 1993-10-21 |
| HAUG, Jonathan Ray | Director | 2015-07-22 | 2018-03-09 |
| HOTCHKISS, Andrew Thomas | Director | 2003-07-01 | 2010-01-01 |
| KADIM, Yuval | Director | 2003-04-01 | 2006-03-17 |
| LEICHT, John George | Director | — | 1993-10-21 |
| LEMEN, Nicholas | Director | 2018-03-09 | 2021-01-01 |
| MAYR, Gerhard Nikolaus | Director | — | 1997-10-01 |
| MORISON, Rebecca Anne | Director | 2016-07-01 | 2018-12-01 |
| NONAKA, Yuya | Director | 2023-02-01 | 2025-08-08 |
| PEZZACK, Susan Dawn | Director | 2014-02-01 | 2016-05-02 |
| PLUMP, Steven Reed | Director | 1997-10-01 | 1999-07-31 |
| PYTYNIA, Thomas Lee | Director | — | 1993-10-21 |
| RICE, Derica Will | Director | 1999-07-01 | 2003-06-30 |
| SEQUEIRA, Ramona | Director | 2010-01-01 | 2012-12-18 |
| VAN DEN BERGH, Albertus Joannes Diminicus Maria | Director | 1995-11-16 | 1997-10-01 |
| ZINN, Eric Marvin | Director | 2011-06-16 | 2015-07-22 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eli Lilly And Company | Corporate entity | Shares 75–100%, Voting 75–100%, right-to-appoint-and-remove-directors-as-firm, significant-influence-or-control-as-firm | 2016-04-06 | Active |
Filing timeline
Last 20 of 177 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-03 | CH01 | officers | Change person director company with change date | |
| 2025-08-19 | AA | accounts | Accounts with accounts type full | |
| 2025-08-14 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-14 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-11-22 | CH01 | officers | Change person director company with change date | |
| 2024-08-24 | AA | accounts | Accounts with accounts type full | |
| 2024-08-05 | CH01 | officers | Change person director company with change date | |
| 2024-07-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-07-05 | TM01 | officers | Termination director company with name termination date | |
| 2023-11-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-09 | AA | accounts | Accounts with accounts type full | |
| 2023-02-16 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-15 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-31 | AA | accounts | Accounts with accounts type full | |
| 2021-11-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-22 | AA | accounts | Accounts with accounts type full | |
| 2021-08-02 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
—
Not reported
-
Net assets
0%
£108,491,000 £108,491,000
-
Employees
—
Not reported
-
Operating profit
0%
£20,000,000 £20,000,000
-
Profit before tax
0%
£20,000,000 £20,000,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers